木瓜直播

Ian Ingram

Ian Ingram

Authors >

Ian Ingram

Ian Ingram joined 木瓜直播 in 2018 as Deputy Managing Editor, and covers oncology for the site. Ian Ingram has been a medical editor for the past decade. Prior to joining 木瓜直播, he was managing editor of Cancer Network, directing the website鈥檚 news coverage and video production. Ian has also worked as a fact-checker, was an assistant editor at Narrative Magazine, and a manuscript reader at the Paris Review. He holds a B.A. in journalism from Purchase College. Ian lives in Connecticut, enjoys tennis, and almost always bowls a perfect game.

Connect:

email image

Latest from Ian Ingram

A close up of a man鈥檚 index finger up his right nostril.

Nose-Picking Health Workers Had Higher COVID Risk

"Deserves more consideration as a potential health hazard," researchers say

FDA APPROVED nirsevimab (Beyfortus) over a computer rendering of respiratory syncytial viruses

New Drug Approved for Preventing RSV in Newborns, Tots

Nirsevimab indicated for all infants, and for kids up to 2 years at high risk

ASCO over a photo of McCormick place in Chicago, IL.

Checkpoint Blockade Stumbles in Advanced EGFR-Mutant NSCLC

"Immediate changes" needed to patient care to avoid unnecessary toxicity, says ASCO expert

ASCO over a photo of McCormick place in Chicago, IL.

New Data in NSCLC Bolster Support for Perioperative Immunotherapy

EFS benefit with pembrolizumab in KEYNOTE-671, but no OS benefit "yet," says investigator

ASCO over a photo of McCormick place in Chicago, IL.

Omitting RT Safe in Many Locally Advanced Rectal Cancers

Most intermediate-risk cases can be cured without pelvic radiation, says investigator

ASCO over a photo of McCormick place in Chicago, IL.

New Standard in Operable EGFR-Positive Lung Cancer

"We should firmly close the door on one-size-fits-all treatment," says ASCO expert

ASCO over a photo of McCormick place in Chicago, IL.

Novel Anti-HER2 Drugs 'Impressive' in Advanced Biliary Cancer

Response rates reached 41-47% with different approaches in rare disease

FDA APPROVED Unadjuvanted, bivalent RSV prefusion F protein vaccine (Abrysvo) over a computer rendering of RSV viruses.

Second RSV Vaccine Lands Approval for Older Adults

Abrysvo approved for adults 60 and up

ASCO over a photo of McCormick place in Chicago, IL.

Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective

Radical resection rate noninferior to open surgery in early-stage disease, with similar survival

FDA ADCOMM obeticholic acid (Ocaliva) over a computer rendering of a liver with fibrosis.

Ocaliva for NASH Gets Thumbs Down From FDA Advisors

Difficulty of risk mitigation for potential drug-induced liver injury weighed heavily on members

鈥�

10

鈥�